GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (HKSE:06955) » Definitions » Gross Profit

Shandong Boan Biotechnology Co (HKSE:06955) Gross Profit : HK$447.3 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Shandong Boan Biotechnology Co Gross Profit?

Shandong Boan Biotechnology Co's gross profit for the six months ended in Dec. 2023 was HK$274.3 Mil. Shandong Boan Biotechnology Co's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was HK$447.3 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Shandong Boan Biotechnology Co's gross profit for the six months ended in Dec. 2023 was HK$274.3 Mil. Shandong Boan Biotechnology Co's Revenue for the six months ended in Dec. 2023 was HK$390.4 Mil. Therefore, Shandong Boan Biotechnology Co's Gross Margin % for the quarter that ended in Dec. 2023 was 70.26%.

Shandong Boan Biotechnology Co had a gross margin of 70.26% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 4 years, the highest Gross Margin % of Shandong Boan Biotechnology Co was 68.65%. The lowest was 66.16%. And the median was 67.11%.


Shandong Boan Biotechnology Co Gross Profit Historical Data

The historical data trend for Shandong Boan Biotechnology Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co Gross Profit Chart

Shandong Boan Biotechnology Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Gross Profit
- 130.42 395.57 447.32

Shandong Boan Biotechnology Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Profit Get a 7-Day Free Trial 119.67 172.63 231.12 173.06 274.27

Competitive Comparison of Shandong Boan Biotechnology Co's Gross Profit

For the Biotechnology subindustry, Shandong Boan Biotechnology Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Boan Biotechnology Co's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shandong Boan Biotechnology Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Shandong Boan Biotechnology Co's Gross Profit falls into.



Shandong Boan Biotechnology Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Shandong Boan Biotechnology Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=676.096 - 228.775
=447.3

Shandong Boan Biotechnology Co's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=390.366 - 116.1
=274.3

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$447.3 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Shandong Boan Biotechnology Co's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=274.3 / 390.366
=70.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Shandong Boan Biotechnology Co  (HKSE:06955) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Shandong Boan Biotechnology Co had a gross margin of 70.26% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Shandong Boan Biotechnology Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Shandong Boan Biotechnology Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Boan Biotechnology Co (HKSE:06955) Business Description

Traded in Other Exchanges
Address
No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.
Executives
Asiapharm Investments Ltd.
Ginkgo (ptc) Limited
Liu Dianbo
Luye Life Sciences Group Ltd
Luye Pharma Holdings Ltd.
Luye Pharma Hong Kong Limited
Luye Pharmaceutical International Co., Ltd.
Luye Pharmaceutical Investment Co., Ltd.
Nelumbo Investments Limited
Shorea Lbg
Luye Pharma Group Ltd.
Shan Dong Lv Ye Zhi Yao You Xian Gong Si
Yan Tai Lv Ye Yi Yao Kong Gu Ji Tuan You Xian Gong Si
Li Li 2201 Interest of corporation controlled by you

Shandong Boan Biotechnology Co (HKSE:06955) Headlines

No Headlines